tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

Base Information

Chemical Name:tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile
CAS No.:1017244-23-3
Molecular Formula:C₂₀H₁₈N₂O₃
Molecular Weight:334.375
Hs Code.:

Synonyms:tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

Suppliers and Price of tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

There total 1 articles about tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 76.0%

: 1017243-99-0
4,5-dihydro-2-(phenylamino)-3-furancarbonitrile

: 2632-13-5
2-Bromo-4'-methoxyacetophenone

: 1017244-23-3
tetrahydro-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(phenylimino)-3-furancarbonitrile

Guidance literature:: 4,5-dihydro-2-(phenylamino)-3-furancarbonitrile; With sodium hydride; In N,N-dimethyl-formamide; at 20 ℃;

2-Bromo-4'-methoxyacetophenone; In N,N-dimethyl-formamide; at 20 ℃; for 1h; Further stages.;
DOI:10.3987/com-07-s(w)16